3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
24
Pancreatic Neoplasms
10
Colonic Neoplasms
10
Rectal Neoplasms
7
Burkitt Lymphoma
7
Adenocarcinoma Of Esophagus
7
Stomach Neoplasms
6
Neoplasm Metastasis
6
Cholangiocarcinoma
6
Esophageal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Adenocarcinoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Leukemia, Biphenotypic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Down Syndrome
2
Carcinoma, Hepatocellular
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Interventions
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Leucovorin
×
30 days
×
Clear all
No trials found.